TB Control - Narcan Spray Kits

The District of Columbia is seeking proposals for a TB Control contract focused on procuring Narcan Spray Kits, a critical public health intervention for opioid overdose prevention. This procurement opportunity was posted on March 3, 2016, with proposals due by March 8, 2016, indicating a compressed timeline for potential vendors. The contract appears to be targeting the procurement of Narcan nasal spray kits, which are used to rapidly reverse opioid overdose effects in emergency situations. While specific technical requirements are not fully detailed in the provided information, the procurement suggests a focus on public health emergency response and harm reduction strategies. The contract seems to be managed directly by the District of Columbia's health or emergency services department, with an emphasis on acquiring medical intervention supplies to address potential overdose scenarios.

Based on the limited information provided, no specific set-aside designations or vendor restrictions are explicitly stated. The brevity of the contract details prevents a comprehensive assessment of potential vendor qualifications or award value ranges. However, the short turnaround time between posting and proposal due dates suggests an urgent procurement need for these critical medical intervention supplies. The contract appears to be a targeted, time-sensitive acquisition of Narcan spray kits, likely intended to support the District of Columbia's public health and emergency response capabilities. Potential vendors would need to demonstrate the ability to quickly supply medical-grade Narcan nasal spray kits that meet standard emergency medical protocols and regulatory requirements.